Company intelligence / Profile preview

Avivagen

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

OxC-beta™ Livestock has demonstrated efficacy as a non-antibiotic alternative to promote growth and maintain health in poultry and swine. Multiple international trials show it performs as well as or better than traditional antibiotic feed additives. The product has regulatory approval or market access in the US, China, Philippines, Taiwan, Thailand, New Zealand, Mexico, Australia and Malaysia. Human application programs are at an earlier stage.

Therapeutic areas: OtherEndocrinologyInfectious Diseases
Modalities: Small molecule (OxC-beta™ technology based on carotenoid oxidation products)Nutraceutical/Feed additive
Industry: Veterinary

Drug pipeline

2 assets

OxC-beta

Commercial

Indications: Livestock growth promotion, Animal immune support

1 more asset in the full pipeline.

Request access →

Partnerships

CSA Animal Nutrition (US distribution partner)COFCO Biotechnology Co. Ltd. research subsidiary (China regulatory/market entry partner)

Beyond the preview

Go deeper on Avivagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avivagen.

Explore the full profile